|
Market Closed -
Nasdaq
01:00:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.340 USD | +24.16% |
|
+9.15% | -94.16% |
| 10-23 | Immutep Limited Announces Health-Related Quality of Life Data from Eftisarc-Neo Phase Ii Trial | CI |
| 10-14 | Immutep outlines clinical development priorities and plans for 2027 | FI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IMM | Delayed | |
OTC Markets
| PRRUF | Delayed | |
|
Deutsche Boerse AG
| YP1B | Delayed | |
|
Tradegate
| YP1B | Real-time | |
|
Börse Stuttgart
| YP1B | Delayed | |
|
Boerse Muenchen
| YP1B | Real-time | |
Nasdaq
| IMMP | Delayed | |
|
CBOE
| IMMP | Real-time | |
|
Tradegate
| YP1 | Real-time | |
|
Deutsche Boerse AG
| YP1 | Delayed | |
|
Börse Stuttgart
| YP1 | Delayed | |
|
Boerse Muenchen
| YP1 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 4.34 | 5.27 | 13.4 |
| Spread/Res. | -23.04% | -36.62% | -75.07% |
| Spread/Supp. | +24.16% | +24.16% | +9.15% |
| Support | 2.69 | 2.69 | 3.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IMM Stock
- IMMP Stock
- Charts Immutep Limited
Select your edition
All financial news and data tailored to specific country editions
